Abstract Number: 2217 • 2016 ACR/ARHP Annual Meeting
Adherence to Drug Therapy in Patients with Fibromyalgia
Background/Purpose: As in other chronic diseases, adherence to the treatment regimen of patients with fibromyalgia (FM) is low (between 30 and 80%), depending on the…Abstract Number: 2218 • 2016 ACR/ARHP Annual Meeting
Do Some Patients with Distal Upper Limb Pain Benefit More Than Others from Advice to Remain Active?
Background/Purpose: We have previously shown that, among patients awaiting physiotherapy for distal upper limb pain/disability, advice to remain active is associated with greater functional recovery…Abstract Number: 2219 • 2016 ACR/ARHP Annual Meeting
Clinical and Radiological Characteristics of Patients with Adhesive Capsulitis and Shoulder Impingement Syndrome
Background/Purpose: Idiopathic adhesive capsulitis is described as a frozen shoulder with severe and global range-of-motion loss of unknown etiology. On the other hand, the most common cause…Abstract Number: 2220 • 2016 ACR/ARHP Annual Meeting
Impact of Fibromyalgia on DAS28 in Patients with Rheumatoid Arthritis
Background/Purpose: To estimate the prevalence of secondary fibromyalgia (FM) in patients with RA and its effect on the disease activity score (DAS28) in a tertiary…Abstract Number: 2221 • 2016 ACR/ARHP Annual Meeting
Recognition of Secondary Fibromyalgia Using an Index of 3 Components of the Multi-Dimensional Health Assessment Questionnaire: 90% Agreement with ACR Criteria for Fibromyalgia
Background/Purpose: Secondary fibromyalgia (FM) is seen 15-20% of patients with rheumatoid arthritis (RA) (1), systemic lupus erythematosus (SLE) (2), osteoarthritis (OA), and other rheumatic diseases.…Abstract Number: 2222 • 2016 ACR/ARHP Annual Meeting
Tai Chi Is More Effective Than Aerobic Exercise in Treating Fibromyalgia: A Randomized Controlled Trial
Background/Purpose: Fibromyalgia is a complex disorder with strong psychological and pain components and is best managed with multidisciplinary therapies. Previous studies have suggested that Tai…Abstract Number: 2223 • 2016 ACR/ARHP Annual Meeting
Can Fibromyalgia be Empirically Defined By the Number of Pain Locations Plus Symptoms?
Background/Purpose: Both the revised 2010 FM criteria (Wolfe et al.) and the 2013 FM criteria (Bennett et al.), rely on counting the number of pain…Abstract Number: 2224 • 2016 ACR/ARHP Annual Meeting
Influence of Caffeine on Opioid Analgesics in Fibromyalgia
Background/Purpose: Caffeine’s action as an NSAID adjuvant are well understood, yet little clinical research has explored its effects on opioid analgesia. We present data from…Abstract Number: 2225 • 2016 ACR/ARHP Annual Meeting
Treatment Outcomes of Newly and Formerly Diagnosed Patients with Fibromyalgia after Fibromyalgia Treatment Program
Background/Purpose: We compared treatment outcomes between newly diagnosed versus formerly diagnosed patients seen in the brief interdisciplinary fibromyalgia treatment program (FTP). The FTP includes diagnostic…Abstract Number: 2226 • 2016 ACR/ARHP Annual Meeting
Independent and Combined Association of Overall Physical Fitness and Subjective Well-Being Components with Fatigue in Fibromyalgia
Background/Purpose: The highest prevalence of severe fatigue in rheumatic diseases is observed in FM1. Physical fitness and subjective well-being have been suggested as resilience resources…Abstract Number: 2227 • 2016 ACR/ARHP Annual Meeting
Sustained Remission and Relapse Rate after Non-Conventional DMARD Withdrawal in Patients with Rheumatoid Arthritis
Background/Purpose: The treatment of rheumatoid arthritis (RA) has evolved continuously. The introduction of non-conventional DMARDs, which include biologic and targeted synthetic DMARDs (tsDMARDs), has been…Abstract Number: 2228 • 2016 ACR/ARHP Annual Meeting
Real-World Cost of Treating Inadequate Responders to Anti-Tumor Necrosis Factor Therapy
Background/Purpose: RA patients (pts) receiving anti-TNF therapy may have an inadequate response (IR) to 1st-line treatment. Among pts for whom treatment fails, little is known…Abstract Number: 2229 • 2016 ACR/ARHP Annual Meeting
Economic Burden of Rheumatoid Arthritis Is Higher for ACPA-Positive Patients
Background/Purpose: Anti-citrullinated protein antibodies (ACPA) have emerged as promising serological biomarkers of rapidly progressing RA and are associated with more severe disease and joint damage.…Abstract Number: 2230 • 2016 ACR/ARHP Annual Meeting
Models Using Claims-Based Administrative Data Are Poor Predictors of Rheumatoid Arthritis Disease Activity in VA Rheumatoid Arthritis (VARA) Patients
Background/Purpose: The goal of this study was to validate a claims-based statistical model to predict disease activity measured by the 28-joint count Disease Activity Score…Abstract Number: 2231 • 2016 ACR/ARHP Annual Meeting
Change in Health Care Utilization after Etanercept Initiation in Patients with Rheumatoid Arthritis
Background/Purpose: Patients with rheumatoid arthritis (RA) have higher healthcare utilization (HCU) and costs than patients without RA1. Evidence is mixed as to the impact of…
ACR Meeting Abstracts